SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001299933-09-004808
Filing Date
2009-12-07
Accepted
2009-12-07 17:27:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_35409.htm 425 26852
2 EX-2.1 exhibit1.htm EX-2.1 280778
3 EX-10.1 exhibit2.htm EX-10.1 21675
4 EX-10.2 exhibit3.htm EX-10.2 21099
5 EX-10.3 exhibit4.htm EX-10.3 41879
6 EX-99.1 exhibit5.htm EX-99.1 13327
  Complete submission text file 0001299933-09-004808.txt   407691
Mailing Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951
Business Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951 215-529-6084
Adamis Pharmaceuticals Corp (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-26372 | Film No.: 091226862
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)